NCT01445548View on ClinicalTrials.gov

Sirolimus for Advanced Age-Related Macular Degeneration

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

April 30, 2013

Study Completion Date

February 28, 2014

Conditions
Age-Related Macular DegenerationGeographic Atrophy
Interventions
DRUG

Sirolimus

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Eye Institute (NEI)

NIH

NCT01445548 - Sirolimus for Advanced Age-Related Macular Degeneration | Biotech Hunter | Biotech Hunter